Tuberculosis

Investigation of human immune signatures of latent MTB infection, active disease and BCG vaccination. (NIH/NIAID, U19 AI118626)

Proteome-wide characterization of T cell epitopes from Mycobacterium tuberculosis in vaccination and active infection. (NIH/NIAID, 75N93019C00067)

Goal: To define MTB-derived T cell epitopes associated with vaccination and active TB infection, and submit them to the IEDB.

About La Jolla Institute

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease. Visit lji.org for more information.

LATEST NEWS

Share this Article:

Portrait photo of Haoyang Li. He is standing outside and smiling at the camera
  • Institute News

LJI Instructor Haoyang Li receives $4.5M to pursue innovative therapeutics for cancers, infectious diseases, and chronic inflammation

Li will capture key immune system molecules in action, with a new R01 grant from the National Institute of Allergy and Infectious Diseases
Read More
  • Research News

A tale of co-evolution: Nuclear speckles aid GC-rich RNA processing

Researchers discover how mysterious cell structures nicknamed "speckles" help our cells stay healthy. 
Read More
Portrait photo of Mitchell Kronenberg, Ph.D.
  • Institute News

The (microbe) highway to the danger zone

LJI Professor Mitchell Kronenberg shows how immune cells defend your most vulnerable organs. His discoveries recently earned top recognition from the American Academy of Microbiology.
Read More